This oncehot cancerdetection company’s stock got cut in half after a failed trial
Feb 20, 2026
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to meet its primary endpoint.
https://www.marketwatch.com/story/this-once-hot-cancer-detection-companys-stock-got-cut-in-half-after-a-failed-trial-1c97caa5?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service